-
Uncategorized1 month ago
Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B
Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B
-
Uncategorized1 month agoPCOS’s new name is PMOS, a small letter change that required a big scientific process
PCOS is dead. Long live PMOS. Revealed Tuesday, the one-letter change in nomenclature for a common metabolic condition in women may seem unremarkable, but it follows...
-
Uncategorized1 month agoSTAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs
Bristol Myers Squibb announced on Tuesday a partnership with Hengrui Pharma covering more than a dozen early-stage programs, the latest and a notably large case of...
-
Uncategorized1 month ago
Stable Producer Cell Line Generation Platform Adds to VIVEbiotech’s Lentiviral Vector Manufacturing Capabilities
VIVEbiotech, a Spanish lentiviral vector (LVV) CDMO, has added EvoLVcell to its catalog of LVV-manufacturing products. EvoLVcell is a stable producer cell line (SCL) generation platform designed...
-
Uncategorized1 month ago
Bristol Myers Squibb inks $15B biobucks deal to bag Hengrui assets, tap China’s R&D speed
Bristol Myers Squibb has formed a broad partnership with Hengrui Pharma, paying $600 million upfront to advance 13 early-stage programs from across the two companies’ pipelines....
-
Uncategorized1 month agoCholesterol Drug May Weaken Ovarian Cancer’s Metastatic Defense
The accumulation of fluid in the belly, known as ascites, is something that women with advanced ovarian cancer may know all too well. The results of...
-
Uncategorized1 month agoSupreme Court temporarily extends women’s access to a widely used abortion pill
WASHINGTON — The Supreme Court is leaving women’s access to a widely used abortion pill untouched until at least Thursday, while the justices consider whether to allow restrictions...
-
Uncategorized1 month ago
Optum Rx unveils pharmacy model with clear fees, building on transparency push
Optum Rx unveils pharmacy model with clear fees, building on transparency push
-
Uncategorized1 month ago
How HIV-1 Develops Resistance to Broadly Neutralizing Antibodies
One of the most challenging aspects of combatting HIV-1 infection is that the virus continually evades neutralizing antibodies. However, one consequence of this is that a...
-
Uncategorized1 month ago
Rezdiffra is exceeding Wall Street’s expectations as the MASH market takes shape
Rezdiffra is exceeding Wall Street's expectations as the MASH market takes shape
